Log in to save to my catalogue

Treatment resistance in psychiatry: state of the art and new directions

Treatment resistance in psychiatry: state of the art and new directions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8960394

Treatment resistance in psychiatry: state of the art and new directions

About this item

Full title

Treatment resistance in psychiatry: state of the art and new directions

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2022-01, Vol.27 (1), p.58-72

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Treatment resistance affects 20–60% of patients with psychiatric disorders; and is associated with increased healthcare burden and costs up to ten-fold higher relative to patients in general. Whilst there has been a recent increase in the proportion of psychiatric research focussing on treatment resistance (
R
2
 = 0.71,
p
 < 0.0001)...

Alternative Titles

Full title

Treatment resistance in psychiatry: state of the art and new directions

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8960394

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8960394

Other Identifiers

ISSN

1359-4184

E-ISSN

1476-5578

DOI

10.1038/s41380-021-01200-3

How to access this item